26 128
Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J.,
Marshall, V.S., and Jones, J.M. (1998). Embryonic stem cell lines derived from
human blastocysts. Science
282
, 1145–1147.
Tsai, S.Q., Wyvekens, N., Khayter, C., Foden, J.A., Thapar, V., Reyon, D., Good-
win, M.J., Aryee, M.J., and Joung, J.K. (2014). Dimeric CRISPRRNA-guided FokI
nucleases for highly specific genome editing. Nat. Biotechnol.
32
, 569–576.
Tsai, S.Q., Zheng, Z., Nguyen, N.T., Liebers, M., Topkar, V.V., Thapar, V., Wy-
vekens, N., Khayter, C., Iafrate, A.J., Le, L.P., et al. (2015). GUIDE-seq enables
genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat.
Biotechnol.
33
, 187–197.
Urbach, A., Schuldiner, M., and Benvenisty, N. (2004). Modeling for Lesch-Ny-
han disease by gene targeting in human embryonic stem cells. Stem Cells
22
,
635–641.
Urnov, F.D., Miller, J.C., Lee, Y.L., Beausejour, C.M., Rock, J.M., Augustus, S.,
Jamieson, A.C., Porteus, M.H., Gregory, P.D., and Holmes, M.C. (2005). Highly
efficient endogenous human gene correction using designed zinc-finger
nucleases. Nature
435
, 646–651.
Urnov, F.D., Rebar, E.J., Holmes, M.C., Zhang, H.S., and Gregory, P.D. (2010).
Genome editing with engineered zinc finger nucleases. Nat. Rev. Genet.
11
,
636–646.
Wang, H., Yang, H., Shivalila, C.S., Dawlaty, M.M., Cheng, A.W., Zhang, F., and
Jaenisch, R. (2013). One-step generation of mice carryingmutations inmultiple
genes by CRISPR/Cas-mediated genome engineering. Cell
153
, 910–918.
Wang, T., Wei, J.J., Sabatini, D.M., and Lander, E.S. (2014a). Genetic screens
in human cells using the CRISPR-Cas9 system. Science
343
, 80–84.
Wang, Y., Liang, P., Lan, F., Wu, H., Lisowski, L., Gu, M., Hu, S., Kay, M.A., Ur-
nov, F.D., Shinnawi, R., et al. (2014b). Genome editing of isogenic human
induced pluripotent stem cells recapitulates long QT phenotype for drug
testing. J. Am. Coll. Cardiol.
64
, 451–459.
Wang, T., Birsoy, K., Hughes, N.W., Krupczak, K.M., Post, Y., Wei, J.J.,
Lander, E.S., and Sabatini, D.M. (2015a). Identification and characterization
of essential genes in the human genome. Science
350
, 1096–1101.
Wang, X., Wang, Y., Wu, X., Wang, J., Wang, Y., Qiu, Z., Chang, T., Huang, H.,
Lin, R.J., and Yee, J.K. (2015b). Unbiased detection of off-target cleavage by
CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors. Nat.
Biotechnol.
33
, 175–178.
Warren, L., Manos, P.D., Ahfeldt, T., Loh, Y.H., Li, H., Lau, F., Ebina, W., Man-
dal, P.K., Smith, Z.D., Meissner, A., et al. (2010). Highly efficient reprogram-
ming to pluripotency and directed differentiation of human cells with synthetic
modified mRNA. Cell Stem Cell
7
, 618–630.
Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya,
T., Takahashi, J.B., Nishikawa, S., Nishikawa, S., Muguruma, K., and Sasai, Y.
(2007). A ROCK inhibitor permits survival of dissociated human embryonic
stem cells. Nat. Biotechnol.
25
, 681–686.
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger,
K., Bernstein, B.E., and Jaenisch, R. (2007). In vitro reprogramming of fibro-
blasts into a pluripotent ES-cell-like state. Nature
448
, 318–324.
Woltjen, K., Michael, I.P., Mohseni, P., Desai, R., Mileikovsky, M., Ha¨ ma¨ la¨ inen,
R., Cowling, R., Wang, W., Liu, P., Gertsenstein, M., et al. (2009). piggyBac
transposition reprograms fibroblasts to induced pluripotent stem cells. Nature
458
, 766–770.
Wood, A.J., Lo, T.W., Zeitler, B., Pickle, C.S., Ralston, E.J., Lee, A.H., Amora,
R., Miller, J.C., Leung, E., Meng, X., et al. (2011). Targeted genome editing
across species using ZFNs and TALENs. Science
333
, 307.
Wu, X., Kriz, A.J., and Sharp, P.A. (2014a). Target specificity of the CRISPR-
Cas9 system. Quant. Biol.
2
, 59–70.
Wu, X., Scott, D.A., Kriz, A.J., Chiu, A.C., Hsu, P.D., Dadon, D.B., Cheng, A.W.,
Trevino, A.E., Konermann, S., Chen, S., et al. (2014b). Genome-wide binding of
the CRISPR endonuclease Cas9 in mammalian cells. Nat. Biotechnol.
32
,
670–676.
Xie, F., Ye, L., Chang, J.C., Beyer, A.I., Wang, J., Muench, M.O., and Kan,
Y.W. (2014). Seamless gene correction of
b
-thalassemia mutations in pa-
tient-specific iPSCs using CRISPR/Cas9 and piggyBac. Genome Res.
24
,
1526–1533.
Xue, H., Wu, S., Papadeas, S.T., Spusta, S., Swistowska, A.M., MacArthur,
C.C., Mattson, M.P., Maragakis, N.J., Capecchi, M.R., Rao, M.S., et al.
(2009). A targeted neuroglial reporter line generated by homologous recombi-
nation in human embryonic stem cells. Stem Cells
27
, 1836–1846.
Yamada, M., Johannesson, B., Sagi, I., Burnett, L.C., Kort, D.H., Prosser,
R.W., Paull, D., Nestor, M.W., Freeby, M., Greenberg, E., et al. (2014). Human
oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid plurip-
otent stem cells. Nature
510
, 533–536.
Yang, H., Wang, H., Shivalila, C.S., Cheng, A.W., Shi, L., and Jaenisch, R.
(2013). One-step generation of mice carrying reporter and conditional alleles
by CRISPR/Cas-mediated genome engineering. Cell
154
, 1370–1379.
Ye, L., Wang, J., Beyer, A.I., Teque, F., Cradick, T.J., Qi, Z., Chang, J.C., Bao,
G., Muench, M.O., Yu, J., et al. (2014). Seamless modification of wild-type
induced pluripotent stem cells to the natural CCR5
D
32 mutation confers resis-
tance to HIV infection. Proc. Natl. Acad. Sci. USA
111
, 9591–9596.
Young, J.E., Boulanger-Weill, J., Williams, D.A., Woodruff, G., Buen, F., Re-
villa, A.C., Herrera, C., Israel, M.A., Yuan, S.H., Edland, S.D., and Goldstein,
L.S. (2015). Elucidating molecular phenotypes caused by the SORL1 Alz-
heimer’s disease genetic risk factor using human induced pluripotent stem
cells. Cell Stem Cell
16
, 373–385.
Young, C.S., Hicks, M.R., Ermolova, N.V., Nakano, H., Jan, M., Younesi, S.,
Karumbayaram, S., Kumagai-Cresse, C., Wang, D., Zack, J.A., et al. (2016).
A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD
Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells. Cell
Stem Cell
18
, 533–540.
Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L.,
Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., et al. (2007). Induced
pluripotent stem cell lines derived from human somatic cells. Science
318
,
1917–1920.
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I.I., and Thomson,
J.A. (2009). Human induced pluripotent stem cells free of vector and transgene
sequences. Science
324
, 797–801.
Yu, Z., Ren, M., Wang, Z., Zhang, B., Rong, Y.S., Jiao, R., and Gao, G. (2013).
Highly efficient genome modifications mediated by CRISPR/Cas9 in
Drosophila. Genetics
195
, 289–291.
Yu, C., Liu, Y., Ma, T., Liu, K., Xu, S., Zhang, Y., Liu, H., La Russa, M., Xie, M.,
Ding, S., and Qi, L.S. (2015). Small molecules enhance CRISPR genome edit-
ing in pluripotent stem cells. Cell Stem Cell
16
, 142–147.
Yusa, K. (2013). Seamless genome editing in human pluripotent stem cells
using custom endonuclease-based gene targeting and the piggyBac trans-
poson. Nat. Protoc.
8
, 2061–2078.
Yusa, K., Rashid, S.T., Strick-Marchand, H., Varela, I., Liu, P.Q., Paschon,
D.E., Miranda, E., Ordo´ n˜ ez, A., Hannan, N.R., Rouhani, F.J., et al. (2011). Tar-
geted gene correction of
a
1-antitrypsin deficiency in induced pluripotent stem
cells. Nature
478
, 391–394.
Zetsche, B., Gootenberg, J.S., Abudayyeh, O.O., Slaymaker, I.M., Makarova,
K.S., Essletzbichler, P., Volz, S.E., Joung, J., van der Oost, J., Regev, A., et al.
(2015). Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas
system. Cell
163
, 759–771.
Zhao, X.Y., Li, W., Lv, Z., Liu, L., Tong, M., Hai, T., Hao, J., Guo, C.L., Ma, Q.W.,
Wang, L., et al. (2009). iPS cells produce viable mice through tetraploid
complementation. Nature
461
, 86–90.
Zhou, Y., Zhu, S., Cai, C., Yuan, P., Li, C., Huang, Y., and Wei, W. (2014). High-
throughput screening of a CRISPR/Cas9 library for functional genomics in
human cells. Nature
509
, 487–491.
Zou, J., Maeder, M.L., Mali, P., Pruett-Miller, S.M., Thibodeau-Beganny, S.,
Chou, B.K., Chen, G., Ye, Z., Park, I.H., Daley, G.Q., et al. (2009). Gene target-
ing of a disease-related gene in human induced pluripotent stem and embry-
onic stem cells. Cell Stem Cell
5
, 97–110.
Zou, J., Mali, P., Huang, X., Dowey, S.N., and Cheng, L. (2011). Site-specific
gene correction of a point mutation in human iPS cells derived from an adult
patient with sickle cell disease. Blood
118
, 4599–4608.
Zwaka, T.P., and Thomson, J.A. (2003). Homologous recombination in human
embryonic stem cells. Nat. Biotechnol.
21
, 319–321.
586
Cell Stem Cell
18
, May 5, 2016
Cell Stem Cell
Review